Xtant Medical Holdings, Inc.
XTNT
$0.51
$0.036.25%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.80% | -6.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.80% | -6.70% | |||
| Cost of Revenue | 33.18% | 2.37% | |||
| Gross Profit | -1.74% | -12.24% | |||
| SG&A Expenses | -10.31% | -7.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.30% | -3.57% | |||
| Operating Income | 50.17% | -28.21% | |||
| Income Before Tax | 36.64% | -29.73% | |||
| Income Tax Expenses | -66.13% | 72.22% | |||
| Earnings from Continuing Operations | 37.00% | -30.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.00% | -30.12% | |||
| EBIT | 50.17% | -28.21% | |||
| EBITDA | 72.86% | -38.81% | |||
| EPS Basic | 46.24% | -25.68% | |||
| Normalized Basic EPS | 46.09% | -25.00% | |||
| EPS Diluted | 50.00% | -33.33% | |||
| Normalized Diluted EPS | 46.09% | -25.00% | |||
| Average Basic Shares Outstanding | 17.14% | 3.71% | |||
| Average Diluted Shares Outstanding | 17.14% | 3.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||